Nicholas Allen Joins DP Clinical as Vice President, Business Development

ROCKVILLE, MD – November 19, 2019 – DP Clinical, Inc., a Contract Research Organization (CRO) specializing in infectious disease, neuroscience, oncology, and ophthalmology Phase I-III clinical programs; continues its growth with the addition of Nicholas Allen as Vice President, Business Development. In this key role, Mr. Allen will draw from his 20 years of sales, marketing, and business development experience in the drug development arena working with large multinational pharmaceutical companies to small, virtual organizations to grow DP Clinical’s market presence and strategic placement within the CRO community.

For the last 9 years, Mr. Allen has been responsible for new business needs in the US and has also focused on Asia-Pacific customers, particularly Japan. Prior to joining DP Clinical, Mr. Allen was the Director of Business Development at a large CRO and was instrumental in establishing their regional office in Japan, an integral part of their corporate strategy for growth in Asia-Pacific. During his career in the industry he as worked in project management as well as in marketing. Nick received his BA Degree in English Literature from the University of Sheffield, Sheffield UK.

“Nick’s wealth of knowledge in business development and experience in clinical research will clearly be an asset to our team,” stated Devinder Poonian, President and CEO. “He is a proven strategic thinker with a pragmatic approach to resolve challenges and implement ideas – these skills are critical to DP Clinical’s growth, particularly in the business development area, and we are excited to have him join our team,” she continued.